Literature DB >> 6186557

Exocrine pancreatic function in insulin-dependent diabetes mellitus.

P G Lankisch, G Manthey, J Otto, H Koop, M Talaulicar, B Willms, W Creutzfeldt.   

Abstract

Exocrine pancreatic function was studied in patients with long-standing insulin-dependent diabetes mellitus using the secretin-pancreozymin test (n = 53), and estimation of immunoreactive trypsin (n = 43) and pancreatic isoamylase (n = 43). The secretin-pancreozymin test was abnormal in 23 patients (43%). The abnormalities found were a decreased output of lipase (37%), amylase (36%) or trypsin (26%) and bicarbonate (15%). Serum immunoreactive trypsin was below normal in only 6 (14%) and pancreatic isoamylase in 29 (67%) patients. There was no correlation between impairment of the secretin-pancreozymin test and decreased serum enzyme levels. It is concluded that an impairment of exocrine pancreatic function is frequent in insulin-dependent diabetics but that a decrease in serum enzymes, especially in pancreatic isoamylase, does not reflect an impairment of pancreatic function in these patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6186557     DOI: 10.1159/000198833

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  38 in total

Review 1.  Abnormalities of the Exocrine Pancreas in Type 1 Diabetes.

Authors:  Martha Campbell-Thompson; Teresa Rodriguez-Calvo; Manuela Battaglia
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

Review 2.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 3.  Diabetes Mellitus Is Associated With an Exocrine Pancreatopathy: Conclusions From a Review of Literature.

Authors:  Sonmoon Mohapatra; Shounak Majumder; Thomas C Smyrk; Lizhi Zhang; Aleksey Matveyenko; Yogish C Kudva; Suresh T Chari
Journal:  Pancreas       Date:  2016-09       Impact factor: 3.327

Review 4.  [Exocrine pancreatic insufficiency and diabetes mellitus].

Authors:  Raimund Weitgasser; Heidemarie Abrahamian; Martin Clodi; Sandra Zlamal-Fortunat; Heinz F Hammer
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

5.  Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?

Authors:  J J Meier; A Bhushan; A E Butler; R A Rizza; P C Butler
Journal:  Diabetologia       Date:  2005-10-05       Impact factor: 10.122

6.  Relationship between circulating levels of pancreatic proteolytic enzymes and pancreatic hormones.

Authors:  Sakina H Bharmal; Sayali A Pendharkar; Ruma G Singh; Mark O Goodarzi; Stephen J Pandol; Maxim S Petrov
Journal:  Pancreatology       Date:  2017-09-20       Impact factor: 3.996

7.  Comparison of BT-PABA test and fecal chymotrypsin measurements in normal subjects and diabetic patients.

Authors:  G Montalto; A Carroccio; G Marino; M Soresi; C Di Marco; A Notarbartolo
Journal:  Acta Diabetol Lat       Date:  1990 Apr-Jun

8.  [Position paper: Exocrine pancreatic insufficiency and diabetes mellitus].

Authors:  Raimund Weitgasser; Heidemarie Abrahamian; Martin Clodi; Werner Fortunat; Heinz Hammer
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

9.  High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study.

Authors:  Philip D Hardt; Annette Hauenschild; Clemens Jaeger; Joachim Teichmann; Reinhard G Bretzel; Hans U Kloer
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

10.  Now that fecal elastase is available in the United States, should clinicians start using it?

Authors:  Paul G Lankisch
Journal:  Curr Gastroenterol Rep       Date:  2004-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.